Navigation Links
Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRST® - Progesterone VGS Compounding Kit

BIRMINGHAM, Ala. June 23, 2011 /PRNewswire/ -- Centrix Pharmaceutical, Inc., a privately-held specialty pharmaceutical company focused on Pediatrics and Women's Health, announces a promotional agreement with CutisPharma, Inc., a Woburn, Massachusetts based company. The partnership will include the promotion of FIRST® - Progesterone VGS, vaginal suppository compounding kits.

Beginning early July, 2011, Centrix Pharmaceutical sales representatives will promote FIRST® - Progesterone VGS compounding kits from CutisPharma, Inc. in physician offices, clinics, and hospitals who specialize in obstetrics and gynecology in addition to retail pharmacies nationwide.

About FIRST® - Progesterone VGS compounding kit

The product line includes FIRST® - Progesterone VGS 25, 50, 100, 200, and 400.  The kits are     made for one patient and include pre-weighed progesterone, and suppository base, and a unique, patented disposable suppository mold for preparation, dispensing, and storage of the suppositories, all in one unit that increases patient compliance, and ease of use.

FIRST® - Progesterone VGS saves dispensing time, and can be compounded by the pharmacist while the patient waits, increasing customer satisfaction. Using FIRST® VGS kits, the pharmacist can compound a prescription for 30 vaginal suppositories 4 to 5 times faster than those prepared in the conventional way using a metal suppository mold or polystyrene shells.  A single NDC number assigned for the entire kit facilitates the third party reimbursement process, and reduces audit-related adjustments.

About Centrix Pharmaceutical, Inc.

Centrix Pharmaceutical is a privately-held specialty pharmaceutical company focused in Pediatrics and Women's Health. Headquartered in Birmingham, AL, the Company's products are marketed by its dedicated sales force in the United States. For more information about Centrix Pharmaceutical, Inc. visit

About CutisPharma, Inc.

CutisPharma, Inc. based in Woburn, MA, is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry. Product line and development efforts initially are focused on providing optimized, more efficient alternatives for the preparation of the nearly 10 million currently compounded prescriptions, by offering FIRST®  Unit-of-Use Prescription Compounding Kits. Use of these branded compounding kits will be beneficial to all triad participants, namely physicians, pharmacists, and patients. Three U.S. patents have been issued to the Company with several additional patents pending. For more information about CutisPharma, Inc., visit

SOURCE Centrix Pharmaceutical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CareCentrix to Present at Hospital Readmissions Conference
2. CareCentrix Appoints Chief Information Officer
3. CareCentrix Receives URAC Health Utilization Management Accreditation
4. TCG Lifesciences Expands Pharmaceutical, Biotechnology Research Initiatives with CAS SciFinder®
5. Omni Bio Pharmaceutical, Incs. CEO Issues Letter to Shareholders
6. Masters Pharmaceutical, Inc. Appoints Wayne A. Corona to President and Chief Operating Officer
7. WellSpring Pharmaceutical, American Gastroenterological Association, and Steven Bramson of Humanscale Partner With MediaPlanet to Publish One of the Largest Digestive Wellness Campaigns in U.S. History to Overcome Upset Stomach, Nausea, IBS, and Deb
8. Ortho-McNeil Pharmaceutical, LLC Pleads Guilty to Illegal Promotion of Topamax and is Sentenced to Criminal Fine of $6.14 Million
9. Shengtai Pharmaceutical, Inc. Reports Financial Results for the Third Quarter and the First Nine Months of Fiscal Year 2010
10. Shengtai Pharmaceutical, Inc Announces Appointment of New Chief Financial Officer
11. National Pharmaceutical Council Welcomes New Member, Otsuka America Pharmaceutical, Inc.
Post Your Comments:
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/24/2016)... June 24, 2016  Consumers have taken a ... have placed more emphasis on patient outcomes. ... programs in the pharmaceutical industry have evolved beyond ... pharmaceutical companies are focusing on becoming more patient-oriented ... products and services that improve health. ...
(Date:6/24/2016)... Mass. , June 24, 2016   ... Spaulding Rehabilitation Network,s Dean Center for Tick ... Physical Medicine and Rehabilitation, MIT Hacking Medicine, University ... for Innovation, today announced the five finalists of ... for Lyme disease.  More than 100 scientists, clinicians, ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):